Asset sale Announced
NueCell Bio acquisition of assets, business operations and customer relationships
Announced 10 Aug 2026
Advisers
assets, business operations and customer relationships
Target
Not disclosed
- Target
- assets, business operations and customer relationships
- Acquirer
- NueCell Bio
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Sector
- Pharma Services
- Tags
- Pharma Services, Cell Therapy
In the league tables
Similar deals
- Kincell Bio and Cellipont Bioservices merger Sep 2026 · Pharma Services
- GI Partners acquisition of CDMO and Cell Solutions businesses of Charles River Laboratories May 2026 · Pharma Services
- Webster Equity Partners acquisition of Lifecore Biomedical Sep 2026 · US$664m · Pharma Services
- Labcorp acquisition of MLM Medical Labs Sep 2026 · Clinical Trial Services
- Advent acquisition of New Zealand Clinical Research Group (NZCR) Sep 2026 · Clinical Trial Services
Sources
- 10 Aug 2026 Goodwin Represents NueCell Bio in its Launch as a New Translational Partner for Cell Therapies goodwinlaw.com
